dipyridamole has been researched along with Epstein-Barr Virus Infections in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Epstein-Barr Virus Infections: Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thomé, MP | 1 |
| Borde, C | 1 |
| Larsen, AK | 1 |
| Henriques, JAP | 1 |
| Lenz, G | 1 |
| Escargueil, AE | 1 |
| Maréchal, V | 1 |
1 other study available for dipyridamole and Epstein-Barr Virus Infections
| Article | Year |
|---|---|
Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation.
Topics: Antiviral Agents; B-Lymphocytes; Cell Line; Dipyridamole; DNA, Viral; Drug Repositioning; Epstein-Ba | 2019 |